251 related articles for article (PubMed ID: 34398560)
1. COVID-19 and Chronic Lymphocytic Leukemia: Where We Stand Now.
Chatzikonstantinou T; Herishanu Y; Montserrat E; Ghia P; Cuneo A; Foà R; Scarfò L
Cancer J; 2021 Jul-Aug 01; 27(4):328-333. PubMed ID: 34398560
[TBL] [Abstract][Full Text] [Related]
2. Chronic Lymphocytic Leukemia in the SARS-CoV-2 Pandemic.
Arellano-Llamas AA; Vela-Ojeda J; Hernandez-Caballero A
Curr Oncol Rep; 2022 Feb; 24(2):209-213. PubMed ID: 35061199
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus.
Scarfò L; Chatzikonstantinou T; Rigolin GM; Quaresmini G; Motta M; Vitale C; Garcia-Marco JA; Hernández-Rivas JÁ; Mirás F; Baile M; Marquet J; Niemann CU; Reda G; Munir T; Gimeno E; Marchetti M; Quaglia FM; Varettoni M; Delgado J; Iyengar S; Janssens A; Marasca R; Ferrari A; Cuéllar-García C; Itchaki G; Špaček M; De Paoli L; Laurenti L; Levin MD; Lista E; Mauro FR; Šimkovič M; Van Der Spek E; Vandenberghe E; Trentin L; Wasik-Szczepanek E; Ruchlemer R; Bron D; De Paolis MR; Del Poeta G; Farina L; Foglietta M; Gentile M; Herishanu Y; Herold T; Jaksic O; Kater AP; Kersting S; Malerba L; Orsucci L; Popov VM; Sportoletti P; Yassin M; Pocali B; Barna G; Chiarenza A; Dos Santos G; Nikitin E; Andres M; Dimou M; Doubek M; Enrico A; Hakobyan Y; Kalashnikova O; Ortiz Pareja M; Papaioannou M; Rossi D; Shah N; Shrestha A; Stanca O; Stavroyianni N; Strugov V; Tam C; Zdrenghea M; Coscia M; Stamatopoulos K; Rossi G; Rambaldi A; Montserrat E; Foà R; Cuneo A; Ghia P
Leukemia; 2020 Sep; 34(9):2354-2363. PubMed ID: 32647324
[TBL] [Abstract][Full Text] [Related]
4. Immune Dysfunction in Patients with Chronic Lymphocytic Leukemia and Challenges during COVID-19 Pandemic.
Langerbeins P; Eichhorst B
Acta Haematol; 2021; 144(5):508-518. PubMed ID: 33631756
[TBL] [Abstract][Full Text] [Related]
5. COVID-19 in Patients with Chronic Lymphocytic Leukemia: What Have We Learned?
Harel R; Itchaki G
Acta Haematol; 2024; 147(1):60-72. PubMed ID: 37820599
[TBL] [Abstract][Full Text] [Related]
6. Coronavirus-Specific Antibody and T Cell Responses Developed after Sputnik V Vaccination in Patients with Chronic Lymphocytic Leukemia.
Komissarov AA; Kislova M; Molodtsov IA; Petrenko AA; Dmitrieva E; Okuneva M; Peshkova IO; Shakirova NT; Potashnikova DM; Tvorogova AV; Ptushkin VV; Efimov GA; Nikitin EA; Vasilieva E
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613860
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 severity and mortality in patients with CLL: an update of the international ERIC and Campus CLL study.
Chatzikonstantinou T; Kapetanakis A; Scarfò L; Karakatsoulis G; Allsup D; Cabrero AA; Andres M; Antic D; Baile M; Baliakas P; Bron D; Capasso A; Chatzileontiadou S; Cordoba R; Correa JG; Cuéllar-García C; De Paoli L; De Paolis MR; Del Poeta G; Demosthenous C; Dimou M; Donaldson D; Doubek M; Efstathopoulou M; Eichhorst B; El-Ashwah S; Enrico A; Espinet B; Farina L; Ferrari A; Foglietta M; Frederiksen H; Fürstenau M; García-Marco JA; García-Serra R; Gentile M; Gimeno E; Glenthøj A; Gomes da Silva M; Gutwein O; Hakobyan YK; Herishanu Y; Hernández-Rivas JÁ; Herold T; Innocenti I; Itchaki G; Jaksic O; Janssens A; Kalashnikova ОB; Kalicińska E; Karlsson LK; Kater AP; Kersting S; Labrador J; Lad D; Laurenti L; Levin MD; Lista E; Lopez-Garcia A; Malerba L; Marasca R; Marchetti M; Marquet J; Mattsson M; Mauro FR; Milosevic I; Mirás F; Morawska M; Motta M; Munir T; Murru R; Niemann CU; Rodrigues RN; Olivieri J; Orsucci L; Papaioannou M; Pavlovsky MA; Piskunova I; Popov VM; Quaglia FM; Quaresmini G; Qvist K; Reda G; Rigolin GM; Ruchlemer R; Saghumyan G; Shrestha A; Šimkovič M; Špaček M; Sportoletti P; Stanca O; Stavroyianni N; Tadmor T; Te Raa D; Tonino SH; Trentin L; Van Der Spek E; van Gelder M; van Kampen R; Varettoni M; Visentin A; Vitale C; Wasik-Szczepanek E; Wróbel T; San Segundo LY; Yassin M; Coscia M; Rambaldi A; Montserrat E; Foà R; Cuneo A; Stamatopoulos K; Ghia P
Leukemia; 2021 Dec; 35(12):3444-3454. PubMed ID: 34725454
[TBL] [Abstract][Full Text] [Related]
8. Treatment approach for elderly and unfit patients with chronic lymphocytic leukemia.
Innocenti I; Autore F; Pasquale R; Morelli F; Efremov DG; Laurenti L
Expert Rev Hematol; 2017 Dec; 10(12):1069-1076. PubMed ID: 29082795
[TBL] [Abstract][Full Text] [Related]
9. Management of chronic lymphocytic leukemia in Canada during the coronavirus pandemic.
Sehn LH; Kuruvilla P; Christofides A; Stakiw J
Curr Oncol; 2020 Jun; 27(3):e332-e335. PubMed ID: 32669941
[TBL] [Abstract][Full Text] [Related]
10. Management of unfit elderly patients with chronic lymphocytic leukemia.
Eichhorst B; Hallek M; Goede V
Eur J Intern Med; 2018 Dec; 58():7-13. PubMed ID: 30527922
[TBL] [Abstract][Full Text] [Related]
11. COVID-19 in patients with chronic lymphocytic leukemia: a multicenter analysis by the Czech CLL study group.
Šimkovič M; Turcsányi P; Špaček M; Mihályová J; Ryznerová P; Maco M; Vodárek P; Écsiová D; Poul H; Móciková H; Zuchnická J; Panovská A; Lekaa M; Oršulová M; Prchlíková A; Stejskal L; Mašlejová S; Brychtová Y; Bezděková L; Papajík T; Lysák D; Trněný M; Smolej L; Doubek M
Ann Hematol; 2023 Apr; 102(4):811-817. PubMed ID: 36847805
[TBL] [Abstract][Full Text] [Related]
12. Vaccination efficacy in patients with chronic lymphocytic leukemia.
Wang KY; Shah P; Skavla B; Fayaaz F; Chi J; Rhodes JM
Leuk Lymphoma; 2023 Jan; 64(1):42-56. PubMed ID: 36270021
[TBL] [Abstract][Full Text] [Related]
13. Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.
Cuneo A; Rigolin GM; Coscia M; Quaresmini G; Scarfò L; Mauro FR; Motta M; Quaglia FM; Trentin L; Ferrario A; Laurenti L; Reda G; Ferrari A; Pietrasanta D; Sportoletti P; Re F; De Paoli L; Foglietta M; Giordano A; Marchetti M; Farina L; Del Poeta G; Varettoni M; Chiurazzi F; Marasca R; Malerba L; Ibatici A; Tisi MC; Stefoni V; Leone M; Baratè C; Olivieri J; Murru R; Gentile M; Sanna A; Gozzetti A; Gattei V; Gottardi D; Derenzini E; Levato L; Orsucci L; Penna G; Chiarenza A; Foà R
Hematol Oncol; 2021 Oct; 39(4):570-574. PubMed ID: 34258787
[No Abstract] [Full Text] [Related]
14. Is There a Role for Cellular Therapy in Chronic Lymphocytic Leukemia?
Dreger P
Cancer J; 2021 Jul-Aug 01; 27(4):297-305. PubMed ID: 34398556
[TBL] [Abstract][Full Text] [Related]
15. An evaluation of zanubrutinib, a BTK inhibitor, for the treatment of chronic lymphocytic leukemia.
Geethakumari PR; Awan F
Expert Rev Hematol; 2020 Oct; 13(10):1039-1046. PubMed ID: 32869675
[TBL] [Abstract][Full Text] [Related]
16. Hypogammaglobulinemia in newly diagnosed chronic lymphocytic leukemia: Natural history, clinical correlates, and outcomes.
Parikh SA; Leis JF; Chaffee KG; Call TG; Hanson CA; Ding W; Chanan-Khan AA; Bowen D; Conte M; Schwager S; Slager SL; Van Dyke DL; Jelinek DF; Kay NE; Shanafelt TD
Cancer; 2015 Sep; 121(17):2883-91. PubMed ID: 25931291
[TBL] [Abstract][Full Text] [Related]
17. Protective role of Bruton tyrosine kinase inhibitors in patients with chronic lymphocytic leukaemia and COVID-19.
Thibaud S; Tremblay D; Bhalla S; Zimmerman B; Sigel K; Gabrilove J
Br J Haematol; 2020 Jul; 190(2):e73-e76. PubMed ID: 32433778
[No Abstract] [Full Text] [Related]
18. B-cell chronic lymphocytic leukemia: recent progress in biology, diagnosis, and therapy.
Montserrat E; Bosch F; Rozman C
Ann Oncol; 1997; 8 Suppl 1():93-101. PubMed ID: 9187440
[TBL] [Abstract][Full Text] [Related]
19. Mechanisms of ibrutinib resistance in chronic lymphocytic leukemia and alternative treatment strategies.
Lama TG; Kyung D; O'Brien S
Expert Rev Hematol; 2020 Aug; 13(8):871-883. PubMed ID: 32673127
[TBL] [Abstract][Full Text] [Related]
20. Chronic Lymphocytic Leukemia Concomitant with COVID 19: A Case Report.
Ali E; Badawi M; Abdelmahmuod E; Kohla S; Yassin MA
Am J Case Rep; 2020 Oct; 21():e926062. PubMed ID: 33098641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
